| Application no. and date | 14717209.2 (espacenet) (Federated) (European Patent Register), 20140326 | | Patent/reg. no. and date | DK/EP 2978746, 20170510 | | Publication date | 20160203 | | Priority no. and date | EP 13161422, 20130327 | | EP pub. no. and date |
EP 2978746 20160203 | | Effective date | | | Applicant/owner | Actelion Pharmaceuticals Ltd., Gewerbestrasse 16
4123 Allschwil, CH | | Applicant ref. no. | P61871DK01 | | Inventor | Abele, Stefan, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
4123 Allschwil, CH,
Funel, Jacques-Alexis, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
4123 Allschwil, CH,
Schindelholz, Ivan, c/o Actelion Pharmaceuticals Ltd
Gewerbestrasse 16
4123 Allschwil, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | C07D 239/47 (2006.01) | | Title | FREMSTILLING AF PYRIMIDINMELLEMPRODUKTER DER ER ANVENDELIGE TIL
FREMSTILLINGEN AF MACITENTAN | | Int. application no. | IB2014060160 | | Int. publication no. | WO2014155304 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
